Limei Han
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Infectious Diseases top 5%
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- RNA Interference and Gene Delivery 4
- DNA Repair Mechanisms 3
-
- Allelopathy and phytotoxic interactions 7
- Co-authors
- Jianxin Wang (9 shared papers)Xiaoling Fang (6 shared papers)John P. Murnane (3 shared papers)Jing Qin (6 shared papers)Keiko Muraki (3 shared papers)Yi Wang (2 shared papers)Xiaoying Fu (2 shared papers)Xiaoxia Wang (2 shared papers)
- Journals
- Research in Veterinary Science (3 papers)Drug Delivery (3 papers)Microbial Pathogenesis (2 papers)Advances in experimental medicine and biology (2 papers)Fitoterapia (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Limei Han
54 papers receiving 1.3k citations
Limei Han's Hit Papers
Peers
Comparison fields: 5 of 113
- Biomaterials 248
- Infectious Diseases 292
- Pharmaceutical Science 90
- Aging 23
- Biomedical Engineering 426
Countries citing papers authored by Limei Han
This map shows the geographic impact of Limei Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Han more than expected).
Fields of papers citing papers by Limei Han
This network shows the impact of papers produced by Limei Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Han. The network helps show where Limei Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Limei Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19 Hit paper breakdown → | 2020 | 351 |
| 2 | 2012 | 118 | |
| 3 | 2006 | 90 | |
| 4 | 2013 | 79 | |
| 5 | 2012 | 78 | |
| 6 | 2017 | 78 | |
| 7 | 2012 | 54 | |
| 8 | 2013 | 48 | |
| 9 | 2012 | 43 | |
| 10 | 2009 | 32 | |
| 11 | 2012 | 27 | |
| 12 | 2013 | 23 | |
| 13 | 2019 | 23 | |
| 14 | 2016 | 20 | |
| 15 | 2019 | 20 | |
| 16 | 2015 | 14 | |
| 17 | 2015 | 14 | |
| 18 | 2014 | 13 | |
| 19 | 2021 | 11 | |
| 20 | 2018 | 8 |
About Limei Han
Limei Han is a scholar working on Molecular Biology, Plant Science, Biomaterials, Pharmacology and Cancer Research, having authored 58 papers that have together received 1.3k indexed citations. Recurring topics across this work include Allelopathy and phytotoxic interactions (7 papers), Nanoparticle-Based Drug Delivery (6 papers), RNA Interference and Gene Delivery (4 papers), Advanced Drug Delivery Systems (4 papers), Telomeres, Telomerase, and Senescence (3 papers), DNA Repair Mechanisms (3 papers), Plant-based Medicinal Research (3 papers) and Herpesvirus Infections and Treatments (3 papers). The work is most often cited by research in Biomaterials (248 citations), Infectious Diseases (292 citations), Pharmaceutical Science (90 citations), Aging (23 citations) and Biomedical Engineering (426 citations). Limei Han has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jianxin Wang, Xiaoling Fang, John P. Murnane, Jing Qin, Keiko Muraki, Yi Wang, Xiaoying Fu, Xiaoxia Wang, Sha Li and Shaojin Chen. Their work appears in journals such as Research in Veterinary Science, Drug Delivery, Microbial Pathogenesis, Advances in experimental medicine and biology and Fitoterapia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.